Shanghai-based NOD Pharmaceuticals Inc. has announced that the U.S. Patent and Trademark Office has approved the patent application for its nano-particle oral delivery technology. NOD technology incorporates peptides or proteins.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
